Pacific Edge launches $20m capital raise

Pacific Edge launches $20m capital raise
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Staff reporters
Pacific Edge has announced a $20 million capital raise, in part to allow it to operate for a year without United States Medicare reimbursement of its tests.The medtech company's non-invasive Cxbladder tests detect bladder cancer by analysing a urine sample for specific genetic markers.Pacific Edge is offering $15m of new ordinary shares to selected investors and $5m of new ordinary shares to its existing retail investors. All Pacific Edge directors intend to take part in the equity raising. The company announced a trading halt on its s...